Options
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Date Issued
2019
Author(s)
Stevenson, Kristen E.
Neuberg, Donna
Maciejewski, Jaroslaw P.
Nazha, Aziz
Sekeres, Mikkael A.
Ebert, Benjamin L.
Garcia-Manero, Guillermo
Haferlach, Claudia
Haferlach, Torsten
Kern, Wolfgang
Ogawa, Seishi
Nagata, Yasunobu
Yoshida, Kenichi
Graubert, Timothy A.
Walter, Matthew J.
List, Alan F.
Komrokji, Rami S.
Padron, Eric
Sallman, David
Papaemmanuil, Elli
Campbell, Peter J.
Savona, Michael R.
Seegmiller, Adam
Adès, Lionel
Fenaux, Pierre
Shih, Lee-Yung
Bowen, David
Groves, Michael J.
Tauro, Sudhir
Fontenay, Michaela
Kosmider, Olivier
Bar-Natan, Michal
Steensma, David
Stone, Richard
Heuser, Michael
Thol, Felicitas
Cazzola, Mario
Malcovati, Luca
Karsan, Aly
Ganster, Christina
Hellström-Lindberg, Eva
Boultwood, Jacqueline
Pellagatti, Andrea
Santini, Valeria
Quek, Lynn
Vyas, Paresh
Tüchler, Heinz
Greenberg, Peter L.
Bejar, Rafael
DOI
10.1038/s41375-018-0351-2
File(s)
No Thumbnail Available
Name
s41375-018-0351-2.pdf
Size
1.66 MB
Checksum (MD5)
68f4ab3c2b48f4eed20de8a53957a6b6
